David Cunningham - Concepedia

Author

David Cunningham

Also Known As

Bryan H. Burmeister, CUNNINGHAM D, CUNNINGHAM, D, Caine, Timothy, Cunningham, D, Cunningham, D., Cunningham, DC, Cunningham, David, Cunningham, David C., Cunningham, D

2.1K

Publications

130.5K

Citations

153

H-Index

372

Concepts

All Affiliations

Royal Marsden Hospital Royal Marsden NHS Foundation Trust University College London Institute of Cancer Research Cancer Research UK

About

David Cunningham is an author at Royal Marsden Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	94	412	46.4K
2	Health Sciences	43	110	10.2K
3	Natural Sciences	10	10	1.7K
4	Engineering	7	7	690
5	Education	2	2	26

David Cunningham

765

Publications

112.6K

Citations

143

H-Index

Page 1

	Year	Citations
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer David Cunningham, William Allum, Sally Stenning, New England Journal of Medicine	2006	6.3K
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer David Cunningham, Yves Humblet, Salvatore Siena, New England Journal of Medicine	2004	5K
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer Juan W. Valle, Harpreet Wasan, Daniel H. Palmer, New England Journal of Medicine	2010	4.3K
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial J-Y Douillard, David Cunningham, AD Roth, The Lancet MedicinePharmacologyColorectal CancerMetastatic Colorectal CancerFirst-line Treatment	2000	3.3K
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial H. Wilke, Kei Muro, Eric Van Cutsem, The Lancet Oncology Surgical OncologyGastrointestinal OncologyMedicinePaclitaxel Versus PlaceboGastroenterology	2014	2.4K
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer David Cunningham, Naureen Starling, Sheela Rao, New England Journal of Medicine	2008	2.3K
Panitumumab–FOLFOX4 Treatment and <i>RAS</i> Mutations in Colorectal Cancer Jean‐Yves Douillard, Kelly S. Oliner, Salvatore Siena, New England Journal of Medicine	2013	2.2K
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers Georgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou, Science	2018	1.9K
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh, The Lancet	2017	1.9K
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor <i>KRAS</i> and <i>BRAF</i> Mutation Status Eric Van Cutsem, Claus-Henning Köhne, István Láng, Journal of Clinical Oncology	2011	1.9K

Page 1